Dr. Habener’s groundbreaking studies in the 1970s and 1980s led to the development of GLP-1 medications for diabetes and obesity.
Dr. Habener’s groundbreaking studies in the 1970s and 1980s led to the development of GLP-1 medications for diabetes and obesity.
